RxCompounded — Not FDA-Approved
Compounded Tirzepatide Injectable
$349/monthor $849/quarter
Tirzepatide is a dual GIP/GLP-1 receptor agonist prescribed for weight management
Physician-supervised care with dose adjustments included and no membership fee
A once-weekly injectable prescribed for weight management
Helps regulate appetite and slows how quickly food moves through the stomach
Used alongside lifestyle changes and continued provider care
Tirzepatide is a dual GIP/GLP-1 receptor agonist
Mimics naturally-occurring hormones released after eating to signal fullness
Helps regulate appetite and blood sugar
Slows digestion to keep you feeling full longer
Compounded to order at a licensed U.S. pharmacy
Compounded tirzepatide is not FDA-approved and is prepared by a licensed compounding pharmacy. It is not the same as any brand-name medication.
Administered as a once-weekly subcutaneous injection
Your provider sets your starting dose and titration schedule
Rotate injection sites with each dose
Store as directed by your pharmacy
Compounded medications are not FDA-approved. By prescription only. A licensed provider determines eligibility. Individual results vary.
